Clara L. Oeste

Clara L. Oeste

Auto-generated profile, based on publicly available information

Clara L. Oeste

LynxCare Inc. , Leuven

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Irene RamosIrene Ramos
Irene Ramos
Konstantinos StamatakisKonstantinos Stamatakis
Konstantinos Stamatakis
COClara L. Oeste
Clara L. Oeste
Dolores Pérez-SalaDolores Pérez-Sala
Dolores Pérez-Sala
Vimentin is an intermediate filament protein that plays key roles in integration of cytoskeletal functions, and therefore in basic cellular processes such as cell division and migration. Consequently, vimentin has complex implications in pathophysiology. Vimentin is required for a proper immune response, but it can also act as an autoantigen in autoimmune diseases or as a damage signal. Although vimentin is a predominantly cytoplasmic protein, it can also appear at extracellular locations, either in a secreted form or at the surface of numerous cell types, often in relation to cell activation, inflammation, injury or senescence. Cell surface targeting of vimentin appears to associate with the occurrence of certain posttranslational modifications, such as phosphorylation and/or oxidative damage. At the cell surface, vimentin can act as a receptor for bacterial and viral pathogens. Indeed, vimentin has been shown to play important roles in virus attachment and entry of severe acute respiratory syndrome-related coronavirus (SARS-CoV), dengue and encephalitis viruses, among others. Moreover, the presence of vimentin in specific virus-targeted cells and its induction by proinflammatory cytokines and tissue damage contribute to its implication in viral infection. Here, we recapitulate some of the pathophysiological implications of vimentin, including the involvement of cell surface vimentin in interaction with pathogens, with a special focus on its role as a cellular receptor or co-receptor for viruses. In addition, we provide a perspective on approaches to target vimentin, including antibodies or chemical agents that could modulate these interactions to potentially interfere with viral pathogenesis, which could be useful when multi-target antiviral strategies are needed.

2 June 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
Dolores Pérez-SalaDolores Pérez-Sala
Dolores Pérez-Sala
COClara L. Oeste
Clara L. Oeste
AMAlma E. Martínez
Alma E. Martínez
MCM. Jesús Carrasco
M. Jesús Carrasco
BGBeatriz Garzón
Beatriz Garzón
FCFrancisco Javier Cañada
Francisco Javier Cañada
The vimentin filament network plays a key role in cell architecture and signalling, as well as in epithelial–mesenchymal transition. Vimentin C328 is targeted by various oxidative modifications, but its role in vimentin organization is not known. Here we show that C328 is essential for vimentin network reorganization in response to oxidants and electrophiles, and is required for optimal vimentin performance in network expansion, lysosomal distribution and aggresome formation. C328 may fulfil these roles through interaction with zinc. In vitro, micromolar zinc protects vimentin from iodoacetamide modification and elicits vimentin polymerization into optically detectable structures; in cells, zinc closely associates with vimentin and its depletion causes reversible filament disassembly. Finally, zinc transport-deficient human fibroblasts show increased vimentin solubility and susceptibility to disruption, which are restored by zinc supplementation. These results unveil a critical role of C328 in vimentin organization and open new perspectives for the regulation of intermediate filaments by zinc.

1 August 2015 in Redox Biology
Verified
Journal Article
Open access
Giancarlo AldiniGiancarlo Aldini
Giancarlo Aldini
MDM Rosario Domingues
M Rosario Domingues
CSCorinne Spickett
Corinne Spickett
PDPedro Domingues
Pedro Domingues
AAAlessandra Altomare
Alessandra Altomare
Dolores Pérez-SalaDolores Pérez-Sala
Dolores Pérez-Sala
Enzymatic and non-enzymatic lipid metabolism can give rise to reactive species that may covalently modify cellular or plasma proteins through a process known as lipoxidation. Under basal conditions, protein lipoxidation can contribute to normal cell homeostasis and participate in signaling or adaptive mechanisms, as exemplified by lipoxidation of Ras proteins or of the cytoskeletal protein vimentin, both of which behave as sensors of electrophilic species. Nevertheless, increased lipoxidation under pathological conditions may lead to deleterious effects on protein structure or aggregation. This can result in impaired degradation and accumulation of abnormally folded proteins contributing to pathophysiology, as may occur in neurodegenerative diseases. Identification of the protein targets of lipoxidation and its functional consequences under pathophysiological situations can unveil the modification patterns associated with the various outcomes, as well as preventive strategies or potential therapeutic targets. Given the wide structural variability of lipid moieties involved in lipoxidation, highly sensitive and specific methods for its detection are required. Derivatization of reactive carbonyl species is instrumental in the detection of adducts retaining carbonyl groups. In addition, use of tagged derivatives of electrophilic lipids enables enrichment of lipoxidized proteins or peptides. Ultimate confirmation of lipoxidation requires high resolution mass spectrometry approaches to unequivocally identify the adduct and the targeted residue. Moreover, rigorous validation of the targets identified and assessment of the functional consequences of these modifications are essential. Here we present an update on methods to approach the complex field of lipoxidation along with validation strategies and functional assays illustrated with well-studied lipoxidation targets.

10 July 2018 in EMBO Reports
Verified
Journal Article
Open access
PDF file
AMAna Martínez‐Riaño
Ana Martínez‐Riaño
EBElena R Bovolenta
Elena R Bovolenta
PMPilar Mendoza
Pilar Mendoza
COClara L Oeste
Clara L Oeste
MMMaría Jesús Martín‐Bermejo
María Jesús Martín‐Bermejo
BSBalbino Alarcón Sánchez
Balbino Alarcón Sánchez
Successful vaccines rely on activating a functional humoral response that results from promoting a proper germinal center (GC) reaction. Key in this process is the activation of follicular B cells that need to acquire antigens and to present them to cognate CD4 T cells. Here, we report that follicular B cells can phagocytose large antigen‐coated particles, a process thought to be exclusive of specialized antigen‐presenting cells such as macrophages and dendritic cells. We show that antigen phagocytosis by B cells is BCR‐driven and mechanistically dependent on the GTPase RhoG. Using Rhog −/− mice, we show that phagocytosis of antigen by B cells is important for the development of a strong GC response and the generation of high‐affinity class‐switched antibodies. Importantly, we show that the potentiation effect of alum, a common vaccine adjuvant, requires direct phagocytosis of alum–antigen complexes by B cells. These data suggest a new avenue for vaccination approaches by aiming to deliver 1–3 μm size antigen particles to follicular B cells.

1 December 2012 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
COClara L. Oeste
Clara L. Oeste
ESEsther Seco
Esther Seco
WPWayne F. Patton
Wayne F. Patton
Patricia BoyaPatricia Boya
Patricia Boya
Dolores Pérez-SalaDolores Pérez-Sala
Dolores Pérez-Sala

21 December 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ABAldo Borroto
Aldo Borroto
DGDiana Reyes Garau
Diana Reyes Garau
M Angeles JimenezM Angeles Jimenez
M Angeles Jimenez
ECEsther Carrasco
Esther Carrasco
BMBeatriz Moreno
Beatriz Moreno
BSBalbino Alarcón Sánchez
Balbino Alarcón Sánchez
Modulating T cell activation is critical for treating autoimmune diseases but requires avoiding concomitant opportunistic infections. Antigen binding to the T cell receptor (TCR) triggers the recruitment of the cytosolic adaptor protein Nck to a proline-rich sequence in the cytoplasmic tail of the TCR’s CD3ε subunit. Through virtual screening and using combinatorial chemistry, we have generated an orally available, low–molecular weight inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 (median inhibitory concentration) ~1 nM. By modulating TCR signaling, the inhibitor prevented the development of psoriasis and asthma and, furthermore, exerted a long-lasting therapeutic effect in a model of autoimmune encephalomyelitis. However, it did not prevent the generation of a protective memory response against a mouse pathogen, suggesting that the compound might not exert its effects through immunosuppression. These results suggest that inhibiting an immediate TCR signal has promise for treating a broad spectrum of human T cell–mediated autoimmune and inflammatory diseases.